Aemetis (NASDAQ:AMTX) Shares Cross Below Two Hundred Day Moving Average – Here’s What Happened

Aemetis, Inc (NASDAQ:AMTX)’s share price crossed below its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $2.34 and traded as low as $1.3518. Aemetis shares last traded at $1.4140, with a volume of 356,142 shares traded.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on AMTX. Ascendiant Capital Markets cut their price objective on shares of Aemetis from $21.00 to $20.00 and set a “buy” rating on the stock in a report on Wednesday, November 19th. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of Aemetis in a research report on Wednesday, October 8th. Three equities research analysts have rated the stock with a Buy rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus target price of $17.00.

Aemetis Trading Down 1.1%

The company has a market capitalization of $90.36 million, a PE ratio of -0.85 and a beta of 2.29. The stock’s fifty day moving average is $1.86 and its two-hundred day moving average is $2.34.

Aemetis (NASDAQ:AMTX) last released its earnings results on Friday, November 7th. The specialty chemicals company reported ($0.37) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.25) by ($0.12). The business had revenue of $59.19 million for the quarter, compared to analysts’ expectations of $87.79 million. As a group, analysts anticipate that Aemetis, Inc will post -2.07 EPS for the current fiscal year.

Institutional Trading of Aemetis

Hedge funds and other institutional investors have recently modified their holdings of the business. Clear Harbor Asset Management LLC raised its holdings in Aemetis by 31.0% during the 2nd quarter. Clear Harbor Asset Management LLC now owns 21,950 shares of the specialty chemicals company’s stock valued at $54,000 after acquiring an additional 5,200 shares during the period. Vanguard Personalized Indexing Management LLC grew its position in shares of Aemetis by 48.7% in the second quarter. Vanguard Personalized Indexing Management LLC now owns 19,611 shares of the specialty chemicals company’s stock valued at $49,000 after purchasing an additional 6,420 shares in the last quarter. Catalyst Funds Management Pty Ltd bought a new stake in shares of Aemetis during the 2nd quarter valued at $25,000. R Squared Ltd purchased a new stake in Aemetis during the 2nd quarter worth about $30,000. Finally, Creative Planning purchased a new stake in Aemetis during the 2nd quarter worth about $30,000. Institutional investors own 27.02% of the company’s stock.

Aemetis Company Profile

Aemetis, Inc, headquartered in Cupertino, California, is a renewable fuels and renewable natural gas producer dedicated to decarbonizing the transportation sector. The company operates two primary business segments: Aemetis Advanced Fuels, which manufactures ethanol, biodiesel and sustainable aviation fuel using patented carbon capture and separation technology; and Aemetis RNG, which develops dairy-based renewable natural gas projects in California for pipeline injection and transportation use.

Since its incorporation in 2006, Aemetis has expanded its production footprint through organic growth and strategic acquisitions.